The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.
Open accessAbstract
Insulin administration to healthy subjects inhibits the production of very low density lipoprotein (VLDL)1 (Svedbergs flotation (Sf) rate 60-400) without affecting that of VLDL2 (Sf 20-60) sub-class. This study was designed to test whether this hormonal action is impaired in non-insulin-dependent diabetes mellitus (NIDDM). We studied six men with NIDDM (age 53 +/- 3 years, body mass index 27.0 +/- 1.0 kg/m2, plasma triglycerides 1.89 +/- 0.22 mmol/l) during an 8.5 h infusion of saline (control) and then in hyperinsulinaemic (serum insulin approximately 540 pmol/l) conditions during 8.5 h infusions of glucose and insulin to give either hyper- and normoglycaemic conditions. [3-2H]-leucine was used as tracer and kinetic constants derived using a non-steady-state multicompartmental model. Compared to the control study, patients with NIDDM reduced VLDL1 apo B production by only 3 +/- 8% after 8.5 h of hyperinsulinaemia (701 +/- 102 vs 672 +/- 94 mg/day respectively, NS) in hyperglycaemic conditions and by 9 +/- 21% under normoglycaemic conditions (603 +/- 145 mg/day). In contrast, in normal subjects insulin induced a 50 +/- 15% decrement in VLDL1 apo B production (p < 0.05). Direct synthesis of VLDL2 apo B in patients with NIDDM was not markedly affected by insulin. We conclude that a contributory factor to hypertriglyceridaemia in NIDDM is the inability of insulin to inhibit acutely the release of VLDL1 from the liver, despite efficient suppression of serum nonesterfied fatty acids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hepatic insulin resistance may contribute to a high production rate of VLDL because insulin reduces apoB synthesis and VLDL secretion in the liver (66, 67).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [66]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
Patsch, J. R., Miesenböck, G., Hopferwieser, T., Mühlberger, V, Knapp, E., Dunn, J. K., Gotto, A. M., & Patsch, W. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1336 · Cited by 1,122
A New and Rapid Method for the Determination of Glucose by Measurement of Rate of Oxygen Consumption
Kadish, A. H., Litle, R. L., & Sternberg, J. (1968) · Clinical Chemistry · doi:10.1093/clinchem/14.2.116 · Cited by 739
Lewis, G., Uffelman, K., Szeto, L., Weller, B., & Steiner, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117633 · Cited by 533
Dixon, J. L., Furukawa, S., & Ginsberg, H. N. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67758-6 · Cited by 420
Dixon, J., & Ginsberg, H. N. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40744-8 · Cited by 368
A microfluorometric method for the determination of free fatty acids in plasma
Miles, J., Glasscock, R., Aikens, J., Gerich, J. E., & Haymond, M. W. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38029-9 · Cited by 329
Lewis, G. F., Uffelman, K. D., Szeto, L., & Steiner, G. A. (1993) · Diabetes · doi:10.2337/diab.42.6.833 · Cited by 323
Kissebah, A. H., Alfarsi, S., & ADAMS, P. W. (1981) · Metabolism · doi:10.1016/0026-0495(81)90064-0 · Cited by 295
A rapid micromethod for apolipoprotein E phenotyping directly in serum
Havekes, L. M., de Knijff, P., Beisiegel†, U., HAVINGA, J. R., de Smit, M. H., & Klasen, E. C. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38697-1 · Cited by 262
Flagged first, then by citations
Research works printed but not linked: 3
- Malmstro ¨m R, Packard CJ, Watson TDG et al. (1997) Met- abolic basis of hypotriglyceridemic effects of insulin in nor- mal men. Arterioscler Thromb Vasc Biol. (In press)
- Lindgren FT, Jensen LC (1972) The isolation and quantita- tive analysis of serum lipoproteins. In: Nelson GJ (ed) Blood lipids and lipoproteins: Quantitation, composition and metabolism. John Wiley & Sons, Livermore, Califor- nia, pp 182-217
- Hardman DA, Kane JP (1986) Isolation and characterisa- tion of apolipoprotein B-48. In: Segrest JP, Albers JJ (eds) Methods in enzymology. Plasma lipoproteins (Part A): Preparation, structure and molecular biology, 128. Aca- demic Press, Orlando, pp 247-262
Cited by
Sorted by citations
Items 201–300 of 318
Brackenridge, A., Jackson, N., Jefferson, W., Stolinski, M., Shojaee‐Moradie, F., Hovorka, R., Umpleby, A. M., & Russell-Jones, D. L. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02729.x · Cited by 15
Determination of acylglycerols from biological samples with chromatography‐based methods
Hellmuth, C., Uhl, O., Segura‐Moreno, M., Demmelmair, H., & Koletzko, B. V. (2011) · Journal of Separation Science · doi:10.1002/jssc.201100556 · Cited by 17
Skrapari, I. C., Perrea, D. N., Ioannidis, I., Karabina, S., Elisaf, M., Tselepis, A. D., Karagiannacos, P., & Katsilambros, N. L. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00538.x · Cited by 15
Rennie, S. M., Park, B. S., & Zammit, V. A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01126.x · Cited by 15
Kubo, M., Fukui, M., Ito, Y., Kitao, T., Shirahase, H., Hinoi, E., & Yoneda, Y. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13236fp · Cited by 15
Duvillard, L., Florentin, E., Pont, F., Petit, J., Baillot-Rudoni, S., Penfornis, A., & Vergès, B. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2946 · Cited by 15
Annuzzi, G., Iovine, C., Mandarino, B., Patti, L., Di Marino, L., Riccardi, G., & Rivellese, A. A. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00779.x · Cited by 13
Gao, H., Xie, C., Wang, H., Yu-jing, L. I. N., & Hong, T. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00534.x · Cited by 13
Tentolouris, N., Boutati, E. I., Karambakalis, N., Perea, D., Tselepis, A. D., Tsoukala, C. G., Kyriaki, D., Lourida, E. S., Anastasopoulou, I., Karafoullidou, A., et al. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2004.06.002 · Cited by 13
de Roos, B. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00614-6 · Cited by 13
Postprandial lipemia in pre- and postmenopausal women
Zaman, G. S., Rahman, S., & Rahman, J. (2012) · Journal of Natural Science Biology and Medicine · doi:10.4103/0976-9668.95961 · Cited by 11
Zhang, H., Yang, H., Lai, C., Xu, X., Huang, K., & Fu, J. (2015) · Clinical Endocrinology · doi:10.1111/cen.12758 · Cited by 12
Postprandial lipemia as an early predictor of cardiovascular complications in childhood obesity
Su, J. W., Nzekwu, M. M. U., Ball, G. D. C., Jetha, M. M., & Proctor, S. D. (2009) · Journal of clinical lipidology · doi:10.1016/j.jacl.2009.02.006 · Cited by 12
Maugeais, C., Ouguerram, K., Krempf, M., & Magot, T. (1998) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1998.131 · Cited by 12
de Pablos-Velasco, P. L., & n, F. J. M. N. M. (1998) · Clinical Drug Investigation · doi:10.2165/00044011-199816050-00003 · Cited by 12
Lindström, T., Nyström, F. H., OLSSON, A. G., Ottosson, A. ‐., & Arnqvist, H. J. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00170.x · Cited by 12
Al-Jiffri, O. H., Al-Sharif, F. M., Jiffri, E. H., & Uversky, V. N. (2016) · Intrinsically Disordered Proteins · doi:10.1080/21690707.2016.1171278 · Cited by 11
Alotaibi, T. F., Thackray, A. E., Roberts, M. J., Alanazi, T. M., BISHOP, N. C., Wadley, A. J., King, J. A., O’Donnell, E., STEINER, M. C., Singh, S. J., et al. (2020) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002560 · Cited by 11
Diabetic dyslipidemia and the metabolic syndrome
Cefalu, W. T. (2008) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2008.04.001 · Cited by 12
Brouwers, M. C. G. J., van Greevenbroek, M. M. J., Vermeulen, V. M. M.-J., van Lin, J. M. J. P., Kallen, C., & de Bruin, T. W. (2007) · Clinical Science · doi:10.1042/cs20070101 · Cited by 11
Adiels, M., Larsson, T. P., Sutton, P., Taskinen, M., Borén, J., & Fielding, B. A. (2010) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.4422 · Cited by 11
Self-citationJohanson, E. H., Jansson, P., Gustafson, B., Sandqvist, M., Taskinen, M., Smith, U., & Axelsen, M. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.542 · Cited by 12
Self-citationBădulescu, O. V., Badescu, C. M., Ciocoiu, M., & Bădescu, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/169420 · Cited by 10
Clinacanthus nutans: Its potential against diabetic vascular diseases
Azemi, A. K., Mokhtar, S. S., & Rasool, A. H. G. (2020) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902020000118838 · Cited by 11
Postprandial Metabolism and Physical Activity in Asians: A Narrative Review
Nagayama, C., Burns, S., Thackray, A., Stensel, D., & Miyashita, M. (2021) · International Journal of Sports Medicine · doi:10.1055/a-1493-2948 · Cited by 9
Physiopathologie de la dyslipidémie du syndrome métabolique et du diabète de type 2
Vergès, B. L. (2007) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2007.01.011 · Cited by 10
Hirano, T. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.65164 · Cited by 10
Uemura, T., Nishimoto, M., Eriguchi, M., Tamaki, H., Tasaki, H., Furuyama, R., Fukata, F., Kosugi, T., Morimoto, K., Matsui, M., et al. (2023) · Hypertension Research · doi:10.1038/s41440-023-01197-y · Cited by 9
Tuvdendorj, D., Zhang, X., Chinkes, D. L., Wang, L., Wu, Z., Rodriguez, N. A., Herndon, D. N., & Wolfe, R. R. (2015) · Metabolism · doi:10.1016/j.metabol.2015.01.002 · Cited by 9
Using mass measurements in tracer studies—a systematic approach to efficient modeling
Ramakrishnan, R., & Ramakrishnan, J. D. (2008) · Metabolism · doi:10.1016/j.metabol.2008.03.011 · Cited by 9
Brouwers, M. C. G. J., van Greevenbroek, M. M. J., Bilderbeek-Beckers, M. A. L., Robertus-Teunissen, M. G., Kallen, C., Stehouwer, C. D. A., & de Bruin, T. W. (2007) · Metabolism · doi:10.1016/j.metabol.2007.05.023 · Cited by 8
Seely, E. W., & Grinspoon, S. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802101-9.00002-8 · Cited by 9
9. ASSEMBLY AND SECRETION OF HEPATIC VERY-LOW-DENSITY LIPOPROTEIN
Gibbons, G. F. (2004) · Principles of medical biology · doi:10.1016/s1569-2582(04)15009-5 · Cited by 8
Physiopathologie de la dyslipidémie du diabète de type 2 : nouvelles perspectives
Vergès, B. L. (2019) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(19)30043-4 · Cited by 7
Relationship Between Renal Function Test Serum and Lipid Profile in Patients with Diabetes Mellitus
Puspitasari, & Aliviameita, A. (2018) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1114/1/012011 · Cited by 7
Dyslipidemia in Type 2 Diabetes and the Effects of Thiazolidinediones
Bell, D. (2003) · The Endocrinologist · doi:10.1097/01.ten.0000098612.88907.4b · Cited by 8
Chadarévian, R., Foubert, L., Beucler, I., Kottler, M., Raisonnier, A., Ajlouni, A., Giral, P., Turpin, G., & Bruckert, É. (2003) · Hormone Research in Paediatrics · doi:10.1159/000071872 · Cited by 7
Lipid Metabolism in Metabolic Syndrome
Borén, J., & Adiels, M. (2013) · Springer eBooks · doi:10.1007/978-3-319-01008-3_8 · Cited by 6
Postprandial Chylomicron Clearance Rate in Late Teenagers with Diabetes Mellitus Type 1
Waarde, W. M. B., Odink, R. J., Rouwé, C. W., Stellaard, F., Westers, M., Vonk, R. J., Sauer, P. J. J., & Verkade, H. J. (2001) · Pediatric Research · doi:10.1203/00006450-200111000-00013 · Cited by 6
Sparks, J. D., Magra, A. L., Chamberlain, J. M., O’Dell, C., & Sparks, C. E. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.11.068 · Cited by 6
Laupsa‐Borge, J., Grytten, E., Bohov, P., Bjørndal, B., Strand, E., Skorve, J., Nordrehaug, J. E., Berge, R. K., Rostrup, E., Mellgren, G., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1020678 · Cited by 5
Treatment of dyslipidemia in patients with diabetes mellitus.
Pikto−Pietkiewicz, W., Wołkowska, K., & Pasierski, T. (2005) · PubMed · Cited by 5
For Debate Diabetes: mellitus or lipidus?
Shafrir, E., & Raz, I. (2003) · Cited by 5
Shekhar, H. U., ., H. M. S., Ahmed, R., ., M. U., & Kaniz-Khatun-E-Janna (2006) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2006.1536.1541 · Cited by 4
Wlazlo, N., & van Greevenbroek, M. M. J. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328354752d · Cited by 4
Brouwers, M. C. G. J., & van Greevenbroek, M. M. J. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328348a5df · Cited by 4
Radziavicius, F. R. C., Alves, B. D. C. A., Feder, D., Maifrino, L. B. M., Azzalis, L. A., Junqueira, V. B. C., Adami, F., Radziavicius, C. C. D. C., de Oliveira, R., & Fonseca, F. L. A. (2018) · Obesity Medicine · doi:10.1016/j.obmed.2018.06.003 · Cited by 3
Cheprasova, A. A., Popov, S. S., Pashkov, A. N., Веревкин, А. Н., Mittova, V. O., & Shulgin, K. K. (2023) · Biomedicine · doi:10.37796/2211-8039.1407 · Cited by 3
Hyperlipidémie des diabétiques
Vergés, B. (2004) · EMC - Endocrinologie - Nutrition · doi:10.1016/j.emcend.2004.02.001 · Cited by 1
Twickler, T. B., Prinsen, H. C. M. T., de Vries, W. R., Koppeschaar, H. P. F., & der Velden, M. G. M. D. S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1907 · Cited by 3
Tessari, P., Kiwanuka, E., Barazzoni, R., TOFFOLO, G. M., Vettore, M., Cortella, I., Manesso, E., Pasqualetto, G., Puricelli, L., Gabelli, C., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2172 · Cited by 3
Production and Metabolism of Triglyceride-Rich Lipoproteins in Both the Normal and Diabetic States
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_6 · Cited by 3
Cardiovascular disease in diabetes: prevention and intervention
Goldberg, R. B., & Florez, H. J. (2001) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200104000-00008 · Cited by 3
Abnormalities in lipoprotein kinetics in Type 2 diabetes
Vergès, B. L. (2010) · Clinical Lipidology · doi:10.2217/clp.10.2 · Cited by 2
Role of enterocytes in dyslipidemia of insulin-resistant states
Nogueira, J. P., & Brites, F. D. (2013) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2012.06.011 · Cited by 2
In Vitro Indicators of Metabolism of Natural Compounds
Shreeve, W. W. (2003) · Springer eBooks · doi:10.1007/978-3-642-55539-8_14 · Cited by 2
Risk Factors and Main Aspects of Lipid Metabolism Disturbances (Literary Review)
Халимович, М. Н., Erkinovna, T. D., Kizi, N. S. N., & Naimov, D. (2023) · Journal Of Advanced Zoology · doi:10.17762/jaz.v44is6.2107 · Cited by 2
Panelli, M. F., Garcia, J. L., de Souza, S. L. B., Costa, M. R., Ferron, A. J. T., Gregolin, C. S., Minatel, I. O., Ferraz, A. P. C. R., Pierine, D. T., Francisqueti‐Ferron, F. V., et al. (2019) · Nutrire · doi:10.1186/s41110-019-0101-x · Cited by 2
Lipid and Lipoprotein Metabolism
Ruotolo, G., & Howard, B. V. (2004) · doi:10.1002/0470862092.d0307 · Cited by 2
The Insulin Resistance Syndrome
Yki‐Järvinen, H. (2004) · Wiley eBooks · doi:10.1002/0470862092.d0410 · Cited by 2
Self-citationCholesterol metabolism in type 2 diabetes
Simonen, P. P. (2002) · Työväentutkimus Vuosikirja · Cited by 2
Pajunen, P. (2002) · Työväentutkimus Vuosikirja · Cited by 2
Atherogenic Lipid Metabolism in Obesity
Toh, S.-A. E. S., Levin, M. G., & Rader, D. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1607-5_15 · Cited by 1
Rôle de l’entérocyte dans les anomalies lipidiques de l’insulinorésistance
Valéro, R., Maraninchi, M., & Nogueira, J. P. (2009) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(09)73619-3 · Cited by 1
Rol del enterocito en la dislipemia de la resistencia insulínica
Nogueira, J. P., & Brites, F. D. (2012) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2012.06.009 · Cited by 1
Production and Metabolism of Triglyceride-Rich Lipoproteins: Impact of Diabetes
Pirillo, A., Norata, G. D., & Catapano, A. L. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_7 · Cited by 3
Systems Biology for Metabolic Disorder and Disease
Sharma, M., & Singh, A. K. (2024) · Springer eBooks · doi:10.1007/978-981-99-9462-5_4 · Cited by 1
Lipid Droplets and Very Low Density Lipoproteins; Their Relation to Insulin Resistance
Olofsson, S., Andersson, L. K., Perman, J., Rutberg, M., Haversen, L., Lu, L., Lu, E., Mobini, R., Ståhlman, M., Myhre, S., et al. (2011) · InTech eBooks · doi:10.5772/21559 · Cited by 1
Candidate genes for obesity and related phenotypes
Swarbrick, M. M. (2002) · UWA Profiles and Research Repository (UWA) · Cited by 1
Masson, C. J. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20130906cm · Cited by 1
(2007) · CRC Press eBooks · doi:10.1201/b13464-12 · Cited by 1
Hepatic steatosis in familial combined hyperlipidemia
Brouwers, M. C. G. J. (2008) · doi:10.26481/dis.20080307mb
Vascular Complications in Diabetes: Risk Factors and Pathogenic Correlates
Chohan, P. K., Netticadan, T., & Dhalla, N. S. (2003) · Progress in experimental cardiology · doi:10.1007/978-1-4615-0455-9_8
Fatty acid metabolism in the metabolic syndrome : effects of dietary fat quantity and quality
van Hees, A. M. J. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20111111ah
Meneses, L. F. (2005) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
LIVER FAT IN THE METABOLIC SYNDROME AND TYPE 2 DIABETES
Kotronen, A. (2008) · Työväentutkimus Vuosikirja
Dyslipidemia among patients visiting tertiary care hospital
Singh, S. P., & Jha, B. K. (2013) · Janaki Medical College Journal of Medical Science · doi:10.3126/jmcjms.v1i2.9264
Lipid metabolism: new approaches to old problems
Taskinen, M., & Ginsberg, H. N. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199806000-00001
Self-citationNOVEL GENES IN THE LIVER OF DIABETIC PSAMMOMYS OBESUS
Southon, A. G. (2002)
Smail, L. (2012) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000203
The involvement of INSIGs, DGAT1 and APOB in human lipid metabolism
Krapivner, S. (2008) · Figshare
Estudio del factor de transcripción SREBP1 en estados de resistencia a insulina.
Miralles, S. V. (2007) · DIGITAL.CSIC (Spanish National Research Council (CSIC))
Magister, M. D. (2013)
I REVIEW Narrative Review: Hepatobiliary Disease in Type 2 Diabetes Mellitus
Tolman, K. G., Fonseca, V. A., Tan, M. H., & Dalpiaz, A. S. (2004)
Veränderungen im Lipoproteinstoffwechsel und dem Insulinsignalweg durch Diät- induzierte Adipositas
Zellbiologie, M., & Beisiegel†, U. (2008)
Endothelial Dysfunction and Dyslipidemia in Type 2 Diabetes: Pathogenesis, Significance and Therapy
Hamilton, S. J., & Watts, G. F. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_13
Nous factors inflamatoris de la diabetis tipus 2: SP-D, SP-A, a-Defensives i visfatina
Juliá, B. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Lipidstoffwechsel und Diabetes
Lackner, K. J. (2001) · Springer eBooks · doi:10.1007/978-3-642-59539-4_18
Insulin's Role as a Vascular Hormone in Health and Disease
Cleland, S. J. (1998) · Enlighten: Theses (The University of Glasgow)
Ng, T. (2007) · UWA Profiles and Research Repository (UWA)
Interactions between carbohydrate and lipid metabolism in metabolic disorders
Bandsma, R. (2004) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Is insulin resistance the principal cause of NAFLD?
Godsland, I. F., Mehta, S., Forbes, S., Meienberg, F., Yee, M. S., Taylor-Robinson, S. D., & Johnston, D. G. (2016) · Wiley eBooks · doi:10.1002/9781118924938.ch3
Fatty acid metabolism in the metabolic syndrome
Blaak, E. E., Saris, W. H. M., & van Hees, A. M. J. (2005)
Minami, A., Sakamoto, S., Ishimura, N., Niwa, Y., & Nakaya, Y. (2000) · The Journal of Japan Atherosclerosis Society · doi:10.5551/jat1973.27.6_133
Adipose tissue metabolism and cardiometabolic health in obesity
Stinkens (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20171005rs
Al-Dahr, M. H. S. (2017) · Advanced Research in Gastroenterology & Hepatology · doi:10.19080/argh.2017.05.555652
Tikka, A., Soronen, J., Laurila, P., Metso, J., Ehnholm, C., & Jauhiainen, M. (2015) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
Metadata
- Authors
- Malmström, R., Packard, C. J., Caslake, M., Bedford, D., Stewart, P., Yki-Järvinen, H., Shepherd, J., & Taskinen, M.-R.
- Affiliations
- University of Helsinki (FI)
- Glasgow Royal Infirmary (GB)
- Venue
- Diabetologia
- Published
- 1997-03-20
- Volume
- 40
- Issue
- 4
- Pages
- 454-462
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2167130513
- Cited by
- 319
- References
- 39
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 7 · 2022: 3 · 2021: 5 · 2020: 6 · 2019: 6 · 2018: 3 · 2017: 4 · 2016: 12 · 2015: 12 · 2014: 15 · 2013: 15 · 2012: 12
- FWCI
- 9.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- British Heart Foundation
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- type 2 diabetes, insulin resistance, triglyceride metabolism, VLDL, VLDL1, apolipoprotein B, hepatic lipoprotein secretion, hypertriglyceridemia, hyperinsulinemia, hyperglycemia, free fatty acids
- MeSH terms
- Apolipoproteins B, Cholesterol, Deuterium, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Humans, Hyperglycemia, Hyperinsulinism, Infusions, Intravenous, Insulin, Leucine, Cholesterol, HDL, Lipoproteins, VLDL, Liver, Male, Middle Aged, Models, Biological, Radioisotope Dilution Technique, Reference Values, Triglycerides, Glucose Clamp Technique
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review